Evidence map›Paper›PMID 27269905›Full record

ArticlePharmacogenomics2016

African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.

Orna Levran, Matthew Randesi, Einat Peles, Joel Correa da Rosa, Jurg Ott, John Rotrosen, Miriam Adelson, Mary Jeanne Kreek

Open access · greenAbstract read
In one paragraph

Article in Pharmacogenomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. [Pharmacological reports : PR · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Acetylcholine Muscarinic MBiological psychiatry · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Orna LevranThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
Matthew RandesiThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
Einat PelesDr Miriam & Sheldon G Adelson Clinic for Drug Abuse Treatment & Research, Tel Aviv Elias Sourasky Medical Center, Tel Aviv, Israel.
Joel Correa da RosaCenter for Clinical & Translational Science, The Rockefeller University, New York, NY 10065, USA.
Jurg OttInstitute of Psychology, Chinese Academy of Sciences, Beijing, China.
John RotrosenVA New York Harbor Healthcare System & NYU School of Medicine, New York, NY 10016, USA.
Miriam AdelsonThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
Mary Jeanne KreekThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
Rockefeller University · USTel Aviv University · ILVA NY Harbor Healthcare System · US

Funding

TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTHUL1RR024143 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2006 to 2011
$49.1M
NCRR NIH HHS UL1 RR024143
6 · The paper itself

Abstract

aimThis study was designed to determine whether polymorphisms in acetylcholine receptors contribute to opioid dependence and/or cocaine dependence. PATIENTS &

methodsThe sample (n = 1860) was divided by drug and ancestry, and 55 polymorphisms (nine genes) were analyzed.

resultsOf the 20 SNPs that showed nominally significant associations, the association of the African-specific CHRM4 SNP rs2229163 (Asn417=) with cocaine dependence survived correction for multiple testing (Pcorrected = 0.047). CHRM4 is located in a region of strong linkage disequilibrium on chromosome 11 that includes genes associated with schizophrenia. CHRM4 SNP rs2229163 is in strong linkage disequilibrium with several African-specific SNPs in DGKZ and AMBRA1.

conclusionCholinergic receptors' variants may contribute to drug addiction and have a potential role as pharmacogenetic markers.

Indexed as

Genetic VariationAdaptor Proteins, Signal TransducingBlack PeopleChromosomes, Human, Pair 11Cocaine-Related DisordersDiacylglycerol KinaseHeroin DependenceHumansLinkage DisequilibriumPolymorphism, GeneticPolymorphism, Single NucleotideReceptor, Muscarinic M4Receptors, MuscarinicSchizophreniaWhite PeopleAdaptor Proteins, Signal TransducingAMBRA1 protein, humanCHRM4 protein, humanDGKZ protein, humanDiacylglycerol KinaseReceptor, Muscarinic M4Receptors, MuscarinicAfrican ancestrycholinergic receptorsCHRM4cocaine addictionopioid addiction

Identifiers

PMID27269905
PMCPMC4996315
OpenAlexW2415218406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.